Skip to main content

Advertisement

SpringerLink
Log in

T-cell replete haploidentical transplantation with reduced post-transplant cyclophosphamide in six children with infantile osteopetrosis

  • Correspondence
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Orchard PJ, Fasth AL, Le Rademacher J, He W, Boelens JJ, Horwitz EM, et al. Hematopoietic stem cell transplantation for infantile osteopetrosis. Blood. 2015;126:270–6.

    Article  CAS  Google Scholar 

  2. Chiesa R, Ruggeri A, Paviglianiti A, Zecca M, Gonzalez-Vicent M, Bordon V, et al. Outcomes after unrelated umbilical cord blood transplantation for children with steopetrosis. Biol Blood Marrow Transpl. 2016;22:1997–2002.

    Article  Google Scholar 

  3. McCurdy SR, Fuchs EJ. Comparable outcomes for hematologic malignancies after HLA-haploidentical transplantation with post transplantation cyclophosphamide and HLA-matched transplantation. Adv Hematol. 2015;2015:431923.

    Article  Google Scholar 

  4. Klein OR, Chen AR, Gamper C, Loeb D, Zambidis E, Llosa N, et al. Alternative-donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for nonmalignant disorders. Biol Blood Marrow Transpl. 2016;22:895–901.

    Article  CAS  Google Scholar 

  5. Natsheh J, Drozdinsky G, Simanovsky N, Lamdan R, Erlich O, Gorelik N, et al. Improved outcomes of hematopoietic stem cell transplantation in patients with infantile malignant osteopetrosis using fludarabine-based conditioning. Pediatr Blood Cancer. 2016;63:535–40.

    Article  CAS  Google Scholar 

  6. Schulz AS, Classen CF, Mihatsch WA, Sigl-Kraetzig M, Wiesneth M, Debatin KM, et al. HLA-haploidentical blood progenitor cell transplantation in osteopetrosis. Blood. 2002;99:3458–60.

    Article  CAS  Google Scholar 

  7. Pronk CJ, Turkiewicz D, Dykes J, Toporski J. Transplantation of maternal haploidentical TcRαβ-depleted stem cells for malignant infantile osteopetrosis–optimal timing and rapid hematological recovery. Blood. 2014;124:5935.

    Article  Google Scholar 

  8. Porta F, Cavagnini S, Imberti L, Sottini A, Bolda F, Beghin A, et al. Partial depletion of TCR alpha/beta+/CD19+ cells in matched unrelated transplantation of three patients with osteopetrosis. Bone marrow Transpl. 2015;50:1583–5.

    Article  CAS  Google Scholar 

  9. Bahr TL, Lund T, Sando NM, Orchard PJ, Miller WP. Haploidentical transplantation with post-transplant cyclophosphamide following reduced-intensity conditioning for osteopetrosis: outcomes in three children. Bone Marrow Transpl. 2016;51:1546–8.

    Article  CAS  Google Scholar 

  10. Neven B, Diana JS, Castelle M, Magnani A, Rosain J, Touzot F, et al. Haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for primary immunodeficiencies and inherited disorders in children. Biol Blood Marrow Transpl. 2019;25:1363–73.

    Article  Google Scholar 

  11. Yuan J, Pei R, Su W, Cao J, Lu Y. Meta-analysis of the actions of antithymocyte globulin in patients undergoing allogeneic hematopoietic cell transplantation. Oncotarget. 2017;8:10871–1082.

    Article  Google Scholar 

  12. Wachsmuth LP, Patterson MT, Eckhaus MA, Venzon DJ, Gress RE, Kanakry CG. Post-transplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression. J Clin Invest. 2019;129:2357–73.

    Article  Google Scholar 

  13. Ayas M, Siddiqui K, Al-Jefri A, Al-Ahmari A, Ghemlas I, Al-Saedi H, et al. Successful outcome in patients with Fanconi Anemia undergoing T cell-replete mismatched related donor hematopoietic cell transplantation using reduced-dose cyclophosphamide post-transplantation. Biol Blood Marrow Transpl. 2019;25:2217–21.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric Hematology/Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

    Amal Al-Seraihy, Hawazen Al-Saedi, Ali Al-Ahmari, Ibrahim Ghemlas & Mouhab Ayas

Authors
  1. Amal Al-Seraihy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hawazen Al-Saedi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ali Al-Ahmari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ibrahim Ghemlas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mouhab Ayas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amal Al-Seraihy.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Al-Seraihy, A., Al-Saedi, H., Al-Ahmari, A. et al. T-cell replete haploidentical transplantation with reduced post-transplant cyclophosphamide in six children with infantile osteopetrosis. Bone Marrow Transplant 56, 1757–1760 (2021). https://doi.org/10.1038/s41409-021-01282-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41409-021-01282-1

  • Springer Nature Limited

This article is cited by

Search

Navigation